Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes
- PMID: 11915023
- DOI: 10.1053/jhep.2002.32533
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes
Abstract
The mechanisms by which bile acids induce apoptosis in hepatocytes and the signaling pathways involved in the control of cell death are not understood fully. Here, we examined the impact of mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3-kinase (PI3K) signaling on the survival of primary hepatocytes exposed to bile acids. Treatment of hepatocytes with deoxycholic acid (DCA), chenodeoxycholic acid (CDCA) or ursodeoxycholic acid (UDCA) caused sustained MAPK activation that was dependent on activation of the epidermal growth factor receptor (EGFR). Activation of MAPK was partially blocked by inhibitors of PI3K. Inhibition of DCA-, CDCA-, and UDCA-stimulated MAPK activation resulted in approximately 20%, approximately 35%, and approximately 55% apoptosis, respectively. The potentiation of DCA- and CDCA-induced apoptosis by MEK1/2 inhibitors correlated with cleavage of procaspase 3, which was blocked by inhibitors of caspase 8 (ile-Glu-Thr-Asp-p-nitroanilide [IETD]) and caspase 3 (DEVD). In contrast, the potentiation of UDCA-induced apoptosis weakly correlated with procaspase 3 cleavage, yet this effect was also blocked by IETD and DEVD. Incubation of hepatocytes with the serine protease inhibitor AEBSF reduced the death response of cells treated with UDCA and MEK1/2 inhibitor to that observed for DCA and MEK1/2 inhibitor. The apoptotic response was FAS receptor- and neutral sphingomyelinase-dependent and independent of FAS ligand expression, and neither chelation of intracellular and extracellular Ca(2+) nor down-regulation of PKC expression altered the apoptotic effects of bile acids. In conclusion, bile acid apoptosis is dependent on the production of ceramide and is counteracted by activation of the MAPK and PI3K pathways.
Comment in
-
Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways.Hepatology. 2002 Apr;35(4):971-3. doi: 10.1053/jhep.2002.32931. Hepatology. 2002. PMID: 11915048 Review. No abstract available.
Similar articles
-
Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53.Hepatology. 2002 Jul;36(1):39-48. doi: 10.1053/jhep.2002.33899. Hepatology. 2002. PMID: 12085347
-
Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.Mol Biol Cell. 2001 Sep;12(9):2629-45. doi: 10.1091/mbc.12.9.2629. Mol Biol Cell. 2001. PMID: 11553704 Free PMC article.
-
Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.Hepatology. 2004 Jun;39(6):1563-73. doi: 10.1002/hep.20246. Hepatology. 2004. PMID: 15185297
-
Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.Dig Dis Sci. 2014 Oct;59(10):2367-80. doi: 10.1007/s10620-014-3190-7. Epub 2014 Jun 11. Dig Dis Sci. 2014. PMID: 25027205 Free PMC article. Review.
-
[Clinical pharmacology of ursodeoxycholic acid (UDCA)].Postepy Hig Med Dosw. 1994;48(1):53-68. Postepy Hig Med Dosw. 1994. PMID: 8058580 Review. Polish.
Cited by
-
Primary biliary cirrhosis: From bench to bedside.World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32. World J Gastrointest Pharmacol Ther. 2015. PMID: 26261733 Free PMC article. Review.
-
Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.Am J Physiol Gastrointest Liver Physiol. 2018 Aug 1;315(2):G259-G271. doi: 10.1152/ajpgi.00354.2017. Epub 2018 Apr 19. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29672156 Free PMC article.
-
Management Of Primary Sclerosing Cholangitis.Gastroenterol Hepatol (N Y). 2006 Nov;2(11):843-849. Gastroenterol Hepatol (N Y). 2006. PMID: 28381955 Free PMC article.
-
Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.Mol Cell Biol. 2003 May;23(9):3052-66. doi: 10.1128/MCB.23.9.3052-3066.2003. Mol Cell Biol. 2003. PMID: 12697808 Free PMC article.
-
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.Clin Rev Allergy Immunol. 2005 Apr;28(2):135-45. doi: 10.1385/CRIAI:28:2:135. Clin Rev Allergy Immunol. 2005. PMID: 15879619 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous